Jacobs Designs Award-Winning Facility for Pfizer

PASADENA, Calif.--(BUSINESS WIRE)--

Jacobs Engineering Group Inc. JEC announced today that a project it executed on behalf of Pfizer Ireland Pharmaceuticals received the 2014 Facility of the Year Award (FOYA) from the International Society for Pharmaceutical Engineering (ISPE), the sponsor of the awards program.

Pfizer Ireland's Network Strategy Implementation Expansion Capacity project re-purposed existing manufacturing space to add capacity for new vaccine and multi-product, small-to-medium scale drug substance bioprocess suites at Pfizer's Grange Castle plant in Clondalkin, South County Dublin.

Jacobs provided design services for the project, utilizing a lean management strategy program during the design process to ensure flow and operations. FOYA judges were impressed with the project team's ability to effectively maintain supply while demolition, construction, start-up and integration activities progressed.

In making the announcement, Jacobs Group Vice President Chris Nagel stated, “It's a pleasure to celebrate the success of this award-winning project with Pfizer. We value our long-standing relationship and appreciate the trust they continue to place in us to support their business needs.”

The FOYA program recognizes pharmaceutical manufacturing projects that use new and innovative technologies to enhance project delivery and reduce production costs of high quality medicines for patients worldwide. Jacobs has designed projects that were selected as the overall FOYA winner for the past three years.

Jacobs, one of the world's largest and most diverse providers of technical professional and construction services, consistently delivers award-winning pharmaceutical and biotechnology projects worldwide.

Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2014 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.